Brean Murray Carret & Co. Starts Johnson & Johnson (JNJ) at Buy
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Price: $261.80 +0.56%
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
23 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Brean Murray Carret & Co. initiates coverage on Johnson & Johnson (NYSE: JNJ) with a Buy. PT $77.
Brean analyst said, "After several years of subpar fundamentals and some unexpected headwinds, J&J appears poised for earnings reacceleration, due to a pipeline-driven revenue upswing in Pharma, stable , MD&D trends and trough for Consumer sales.
For more ratings news on Johnson & Johnson click here and for the rating history of Johnson & Johnson click here.
Shares of Johnson & Johnson closed at $67.10 yesterday.
Brean analyst said, "After several years of subpar fundamentals and some unexpected headwinds, J&J appears poised for earnings reacceleration, due to a pipeline-driven revenue upswing in Pharma, stable , MD&D trends and trough for Consumer sales.
For more ratings news on Johnson & Johnson click here and for the rating history of Johnson & Johnson click here.
Shares of Johnson & Johnson closed at $67.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
New CoverageRelated Entities
Brean Murray Carret & Co., EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
